Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 482-670-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
LD50 oral, rat > 2000 mg/kg bw
LD50 dermal, rat > 2000 mg/kg bw
Key value for chemical safety assessment
Additional information
Neodymium tris(di-2-ethylhexylphosphate) was tested in one oral and one dermal acute toxicity study, both performed according to internationally recognised guidelines and GLP, scored as validity 1 according to Klimisch criteria, and considered as key studies acceptable for the assessment.
Acute toxicity: oral
In an acute oral toxicity study according to OECD 423, EC B.1 tris, US/EPA/OPPTS 870.1100 and GLP (CIT report 32229 TAR, 2007), scored as validity 1 according to Klimisch criteria, groups of fasted 8-week old Sprague-Dawley rats were given a single oral dose of neodymium tris(di-2-ethylhexylphosphate) in corn oil at the dose of 300 and 2000 mg/kg bw (3 and 2x3 females, respectively). Animals were observed for 14 days. Clinical signs and mortality were checked frequently during the hours following administration of the test substance, and at least once a day thereafter. Body weight was measured just before administration of the test substance on day 1 and then on days 8 and 15.
No mortality occurred during the study.
At 300 mg/kg, piloerection and dyspnea were noted in all the animals one hour after treatment. Piloerection was still observed 2 hours after treatment. At 2000 mg/kg, piloerection was noted in 3/6 females 4 hours after treatment only.
No other clinical signs were noted thereafter, until the end of the observation period.
A slightly lower body weight gain was noted between day 8 and day 15 in 1/6 females treated at the dose-level of treated at 2000 mg/kg, when compared to historical control animals. The overall body weight gain of the other animals treated at the dose-level of 300 or 2000 mg/kg was not affected by treatment with the test item.
At necropsy, no apparent abnormalities were observed in any animal.
Under the experimental conditions, the oral LD50 of the test item neodymium tris(di-2-ethylhexylphosphate) was higher than 2000 mg/kg in rats.
No classification for acute oral toxicity is warranted based on the absence of mortality up to 2000 mg/kg bw, according to the criteria of Annex VI Directive 67/548/EEC or UN/EU GHS.
Acute toxicity: dermal
In an acute dermal toxicity study according to OECD TG 402, EC B.3, OPPTS 870.1200 and GLP (CIT report No.33192 TAR, 2007), scored as validity 1 according to Klimisch criteria, a group of 8-week old Sprague-Dawley rats (5/sex) were applied a single dermal dose of undiluted neodymium tris(di-2-ethylhexylphosphate) at the dose of 2000 mg/kg bw (limit test) under a semi-occlusive dressing applied for 24 hours, and observed for 14 days. Clinical signs and mortality were checked frequently during the hours following administration of the test substance, and at least once a day thereafter. Body weight was measured just before administration of the test substance on day 1 and then on days 8 and 15. Local tolerance was also observed from Day 2.
No deaths and no systemic clinical signs were observed during the study.
Crusts were noted in one female from day 11 until day 15 (end of the observation period).
When compared to historical control animals, a slightly lower body weight gain was noted in 1/5 females between day 8 and day 15. The overall body weight gain of the other animals was not affected by treatment with the test item.
No apparent abnormalities were observed at necropsy in any animal.
Under the experimental conditions of this study, the dermal LD50 of the test item neodymium tris(di-2-ethylhexylphosphate) was higher than 2000 mg/kg bw in rats.
No classification for acute dermal toxicity is warranted based on the absence of mortality up to a limit dose level, according to the criteria of Annex VI Directive 67/548/EEC or UN/EU GHS.
Acute toxicity: inhalation
No acute inhalation toxicity study is available. However this study can be waived based on column 2 adaptation (Reach regulation, Annex VIII, section 8.5), and because exposure of humans via inhalation is unlikely; handling of the registered substance does not produce vapour, aerosols or droplets. Furthermore, the substance is produced as an intermediate under strictly controlled conditions, thus no additional testing is required.
Justification for classification or non-classification
Based on the data available which induced no mortality in the rat following a single exposure by oral and dermal route up to a limit dose of 2000 mg/kg bw, neodymium tris(di-2-ethylhexylphosphate) should not be classified for acute toxicity via the oral and dermal route as defined by the criteria of Annex VI Directive 67/548/EEC or UN/EU GHS classification criteria.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.